Suggestions
Barbara Ratto
Director, Oncology Global Value & Access Product Lead, RCC & Metastatic/Adjuvant Melanoma Portfolio at Novartis
Barbara Ratto is a highly experienced professional with over 19 years of work in Medicine, Internal Medicine, Clinical Oncology, Radiation Oncology, Medical Auditing, and Health Economics both in Argentina and the USA.
Her educational background includes various post-graduate courses in Medical Research, Health Technology Assessment (HTA), and specialized residencies and programs in Radiation Oncology, Clinical Oncology, and Internal Medicine.
Barbara has held key positions in renowned organizations such as Novartis, where she served as Director of Oncology Global Value & Access, leading portfolios in Renal Cell Carcinoma, Metastatic/Adjuvant Melanoma, and HEOR & Market Access in Latin America and Canada regions.
With a strong foundation in Health Economics and Outcomes Research (HEOR), Barbara possesses a comprehensive understanding of global medical research and reimbursement landscapes.
Throughout her career, Barbara has excelled in roles including Medical Information Lead, Medical Scientific Liaison, Access Medical Manager, and various auditing and medical plant positions in prestigious medical facilities and pharmaceutical companies.
Her expertise spans medical auditing, pharmaceutical product leads, market access, HEOR strategies, oncology medical information, and liaison roles in oncology and solid tumors.
Barbara Ratto's diverse skill set and extensive professional experience make her a highly valuable asset in the healthcare and pharmaceutical industry.